IP Library Granted Patent US 11,473,052
Granted Patent B2
US 11,473,052 · App. 15/542,135 · Granted Oct 18, 2022

Patent

Inventors: Derrick Lewis (Durham, NC); Marianne Thorup Cohn (Copenhagen, DK); Adam Nelson (Salem, VA); Preben Nielsen (Horsholm, DK); Ravi Kumar (Davis, CA)
Assignee: Novozymes A/S
C12N1/20A23K10/18A61K35/742A61P31/04C12N1/205A61K2035/115C12R2001/125Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,473,052
App. No.
15/542,135
Granted
Oct 18, 2022
Kind
B2
Abstract

The present invention relates to novel subspecies of Bacillus . The novel subspecies can improve health and performance of production animals. In one embodiment the Bacillus subtilis subspecies has activity against Clostridium perfringens and/or E. coli . The invention further relates to compositions comprising one or more strains of the Bacillus subtilis subspecies and to use of the strain(s) of the Bacillus subtilis subspecies in an animal feed.

Claims (7)

1. A method comprising administering Bacillus subtilis DSM 29870 to an animal.

2. The method of claim 1 , wherein said Bacillus subtilis DSM 29870 is administered to said animal via feeding.

3. The method of claim 1 , wherein said Bacillus subtilis DSM 29870 is administered to said animal as part of an animal feed composition or an animal feed additive composition.

4. The method of claim 1 , wherein said Bacillus subtilis DSM 29870 is administered to said animal as part of a composition comprising from 10 5 to 10 12 colony-forming units of Bacillus subtilis DSM 29870 per gram of said composition.

5. The method of claim 1 , wherein said Bacillus subtilis DSM 29870 is administered to said animal as part of a composition comprising Bacillus subtilis DSM 29870 spores.

6. The method of claim 1 , wherein said Bacillus subtilis DSM 29870 is administered to said animal as part of a composition comprising one or more of the following: glycerol, ethylene glycol, 1,2-propylene glycol, 1,3-propylene glycol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium thiosulfate, calcium carbonate, sodium citrate, dextrin, glucose, sucrose, sorbitol, lactose, starch and cellulose.

7. The method of claim 1 , wherein said Bacillus subtilis DSM 29870 is administered to said animal as part of an animal feed composition or animal feed additive composition comprising from 10 5 to 10 12 colony-forming units of Bacillus subtilis DSM 29870 per gram of said composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2017
From: LEWIS, DERRICK; COHN, MARIANNE THORUP; NELSON, ADAM; NIELSEN, PREBEN; KUMAR, RAVI
To: NOVOZYMES A/S
Reel/Frame 042929/0954 →
Continuity (4)
Provisional Application 62106841 · Jan 23, 2015
Provisional Application 62153038 · Apr 27, 2015
Provisional Application 62260800 · Nov 30, 2015
Related Publication 20180258502A1 · Sep 13, 2018
Cited By (2)
US 12,364,720 US 12,742,146